What Sparked AbCellera Biologics To Soar Over 9% After Hours - AbCellera Biologics (NASDAQ:ABCL)

Core Viewpoint - AbCellera Biologics Inc. shares experienced a significant increase following the release of its fourth-quarter 2025 earnings, indicating positive market reaction to the company's performance [2]. Financial Performance - The company reported earnings per share of negative $0.03, outperforming the estimate of negative $0.18 by 83.33% [2]. - Revenue increased by $39.80 million compared to the previous year [2]. - The fourth-quarter results followed a challenging third quarter of 2025, where the company missed earnings per share estimates by $0.02 [3]. Trading Metrics and Technical Analysis - AbCellera Biologics has a market capitalization of $963.86 million, with a 52-week high of $6.52 and a low of $1.89 [4]. - The stock has a Relative Strength Index (RSI) of 44.92 and has delivered a 14.18% gain over the past 12 months [4]. - The stock closed at $3.22, up 6.27% on Tuesday, and is approximately 28.7% above its 52-week low [4]. Market Sentiment - Benzinga's Edge Stock Rankings indicate that AbCellera Biologics has a negative price trend across all time frames [5].